Plain-English translation of NCT07059962 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Kidney Disease research guide โThis trial is testing a wearable device called the Bodyport Cardiac Scale โ a special bathroom scale that measures fluid and heart function โ to see if it can predict when dialysis patients might develop serious problems from fluid overload. Researchers want to understand whether the measurements from this scale can warn doctors early enough to prevent hospital visits or other complications. If successful, this could help people on peritoneal dialysis stay healthier by catching problems before they become serious.
People with kidney failure on peritoneal dialysis often struggle with fluid buildup in their bodies, which can lead to dangerous complications and hospital stays. Right now, doctors don't have a simple, early-warning way to catch these problems before they happen. This study exists to see whether a wearable scale can give patients and doctors that early warning.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
As a participant, you would use the Bodyport Cardiac Scale โ a special wearable scale that measures your body's fluid and heart function โ at home as part of your regular dialysis routine. The study team will track these measurements over time to see if they can predict when you might develop fluid-related problems. You'll continue your normal peritoneal dialysis treatment while providing these regular scale readings to help researchers understand whether this tool works.
AI-generated summary from trial data ยท Jun 12, 2026 ยท Not medical advice
United States
Canada